268 related articles for article (PubMed ID: 27480161)
1. Community attitudes towards a Jewish community BRCA1/2 testing program.
Cousens N; Kaur R; Meiser B; Andrews L
Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
3. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
4. Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Rosenthal E; Moyes K; Arnell C; Evans B; Wenstrup RJ
Breast Cancer Res Treat; 2015 Jan; 149(1):223-7. PubMed ID: 25476495
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two population screening programmes for
Cousens NE; Tiller J; Meiser B; Barlow-Stewart K; Rowley S; Ko YA; Mahale S; Campbell IG; Kaur R; Bankier A; Burnett L; Jacobs C; James PA; Trainer A; Neil S; Delatycki MB; Andrews L
BMJ Open; 2021 Jun; 11(6):e041186. PubMed ID: 34172541
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
[TBL] [Abstract][Full Text] [Related]
7. Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.
Tennen RI; Laskey SB; Koelsch BL; McIntyre MH; Tung JY
Sci Rep; 2020 May; 10(1):7669. PubMed ID: 32376921
[TBL] [Abstract][Full Text] [Related]
8. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
Lucas AL; Frado LE; Hwang C; Kumar S; Khanna LG; Levinson EJ; Chabot JA; Chung WK; Frucht H
Cancer; 2014 Jul; 120(13):1960-7. PubMed ID: 24737347
[TBL] [Abstract][Full Text] [Related]
10. A family with three germline mutations in BRCA1 and BRCA2.
Liede A; Metcalfe K; Offit K; Brown K; Miller S; Narod SA; Moslehi R
Clin Genet; 1998 Sep; 54(3):215-8. PubMed ID: 9788724
[TBL] [Abstract][Full Text] [Related]
11. The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.
Gal I; Gershoni Baruch R; Haber D; Dagan E; Eisenberg-Barzilai S; Zidan J; Friedman E
Fam Cancer; 2004; 3(1):11-4. PubMed ID: 15131400
[TBL] [Abstract][Full Text] [Related]
12. Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA).
Apicella C; Andrews L; Hodgson SV; Fisher SA; Lewis CM; Solomon E; Tucker K; Friedlander M; Bankier A; Southey MC; Venter DJ; Hopper JL
Breast Cancer Res; 2003; 5(6):R206-16. PubMed ID: 14580256
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E
Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684
[TBL] [Abstract][Full Text] [Related]
14. A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of
Best AF; Tucker MA; Frone MN; Greene MH; Peters JA; Katki HA
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):293-302. PubMed ID: 30692095
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas.
Trottier M; Lunn J; Butler R; Curling D; Turnquest T; Francis W; Halliday D; Royer R; Zhang S; Li S; Thompson I; Donenberg T; Hurley J; Akbari MR; Narod SA
Clin Genet; 2016 Mar; 89(3):328-31. PubMed ID: 25920394
[TBL] [Abstract][Full Text] [Related]
16. Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalities.
Augustyn AM; Agostino NM; Namey TL; Nair S; Martino MA
Breast Cancer Res Treat; 2011 Sep; 129(2):629-34. PubMed ID: 21607582
[TBL] [Abstract][Full Text] [Related]
17. The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations.
Barnes-Kedar I; Bernstein-Molho R; Ginzach N; Hartmajer S; Shapira T; Magal N; Kalis ML; Peretz T; Shohat M; Basel-Salmon L; Friedman E; Bazak L; Goldberg Y
Breast Cancer Res Treat; 2018 Nov; 172(1):151-157. PubMed ID: 30014164
[TBL] [Abstract][Full Text] [Related]
18. Population-based
Tiller JM; Cousens NE; Kaur R; Rowley S; Ko YA; Mahale S; Bankier A; Meiser B; Barlow-Stewart K; Burnett L; Jacobs C; James P; Trainer A; Neil S; Campbell IG; Andrews L; Delatycki M
J Med Genet; 2023 Mar; 60(3):265-273. PubMed ID: 36763037
[TBL] [Abstract][Full Text] [Related]
19. [BRCAmutations more frequent in people of Jewish ancestry].
Menko FH; Rosenberg EH; van der Kolk LE
Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30875152
[TBL] [Abstract][Full Text] [Related]
20. Population-Based Study of Attitudes toward BRCA Genetic Testing among Orthodox Jewish Women.
Tang EY; Trivedi MS; Kukafka R; Chung WK; David R; Respler L; Leifer S; Schechter I; Crew KD
Breast J; 2017 May; 23(3):333-337. PubMed ID: 27900810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
